微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 4.02% | 605.26% | 155.83% | 16/68 | 2.31% | 沃华医药 | 9.22% | 行业排名> |
| 2025-12-31 | -7.2% | -1484.62% | -4335.29% | 56/68 | 2.77% | 羚锐制药 | 6.99% | 行业排名> |
| 2025-09-30 | 0.17% | -90% | 118.89% | 56/68 | 4.88% | 羚锐制药 | 22.39% | 行业排名> |
| 2025-06-30 | -0.9% | -234.33% | -257.89% | 57/68 | 3.21% | 达仁堂 | 25.38% | 行业排名> |
| 2025-03-31 | 0.57% | -47.22% | 9.62% | 51/68 | 2.25% | 羚锐制药 | 13.67% | 行业排名> |
| 2024-12-31 | 0.52% | -58.06% | -69.41% | 50/68 | 3.28% | 天目药业 | 9.27% | 行业排名> |
| 2024-09-30 | 1.7% | 753.85% | 153.73% | 52/68 | 5.46% | 天目药业 | 22.26% | 行业排名> |
| 2024-06-30 | 0.67% | -4.29% | -37.96% | 52/68 | 2.54% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-03-31 | 1.08% | 6.93% | -12.9% | 47/68 | 1.97% | 羚锐制药 | 13.25% | 行业排名> |
| 2023-12-31 | 1.24% | -70.75% | 576.92% | 54/68 | 2.03% | XD片仔癀 | 7.03% | 行业排名> |
| 2023-09-30 | -0.26% | -104.7% | -137.14% | 61/68 | 7.62% | XD片仔癀 | 23.1% | 行业排名> |
| 2023-06-30 | 0.7% | -60.23% | -30.69% | 59/68 | 5.2% | 太极集团 | 22.08% | 行业排名> |
| 2023-03-31 | 1.01% | 6.32% | -76.18% | 55/68 | 3.31% | 太极集团 | 17.13% | 行业排名> |
| 2022-12-31 | 4.24% | -19.24% | -23.33% | 43/68 | 6.79% | 以岭药业 | 10.43% | 行业排名> |
| 2022-09-30 | 5.53% | -5.15% | 214.2% | 40/68 | 5.19% | *ST吉药 | 72.63% | 行业排名> |
| 2022-06-30 | 1.76% | -48.69% | 85.26% | 52/68 | 3.33% | XD片仔癀 | 23.54% | 行业排名> |
| 2022-03-31 | 0.95% | -9.52% | -81.9% | 51/68 | 2.18% | XD片仔癀 | 19.69% | 行业排名> |
| 2021-12-31 | 5.25% | -50.38% | -9.95% | 44/68 | 4.51% | XD片仔癀 | 12.75% | 行业排名> |
| 2021-09-30 | 5.83% | 22.22% | 69.97% | 43/68 | 7.47% | XD片仔癀 | 6.88% | 行业排名> |
| 2021-06-30 | 3.43% | -31.26% | 226.67% | 44/68 | 4.6% | XD片仔癀 | 27.39% | 行业排名> |
| 2021-03-31 | 1.05% | -3.67% | -90.08% | 54/68 | 2.63% | XD片仔癀 | 23.14% | 行业排名> |
| 2020-12-31 | 10.58% | 8.96% | 121.8% | 23/68 | 0.07% | XD片仔癀 | 13.23% | 行业排名> |
| 2020-09-30 | 4.77% | -41.18% | -4.41% | 43/68 | 6.89% | 长药退 | 7.37% | 行业排名> |
| 2020-06-30 | 4.99% | 51.21% | 357.8% | 23/68 | 3.83% | 以岭药业 | 7.15% | 行业排名> |
| 2020-03-31 | 1.09% | -46.04% | -88.77% | 51/68 | 2.18% | 沃华医药 | 22.84% | 行业排名> |
| 2019-12-31 | 9.71% | 80.82% | 19.73% | 29/68 | 6.88% | 沃华医药 | 19.47% | 行业排名> |
| 2019-09-30 | 8.11% | 127.81% | 145.76% | 29/68 | 7.39% | 沃华医药 | 12.7% | 行业排名> |
| 2019-06-30 | 3.3% | 39.83% | 63.37% | 45/68 | 4.75% | 济川药业 | 7.33% | 行业排名> |
| 2019-03-31 | 2.02% | 210.77% | -62.38% | 43/68 | 2.94% | 济川药业 | 27.43% | 行业排名> |
| 2018-12-31 | 5.37% | 16.49% | 50.84% | 47/68 | 7.89% | 济川药业 | 23.05% | 行业排名> |
| 2018-09-30 | 3.56% | -18.91% | 50.85% | 50/68 | 8.02% | 济川药业 | 15.79% | 行业排名> |
| 2018-06-30 | 2.36% | 16.26% | 263.08% | 48/68 | 5.05% | 华润三九 | 10.23% | 行业排名> |
| 2018-03-31 | 0.65% | 20.37% | -85.9% | 58/68 | 2.78% | 济川药业 | 32.79% | 行业排名> |
| 2017-12-31 | 4.61% | -0.65% | 5.01% | 52/68 | 9.95% | 济川药业 | 27.55% | 行业排名> |
| 2017-09-30 | 4.39% | 4.28% | 116.26% | 50/68 | 8.4% | 济川药业 | 17.62% | 行业排名> |
| 2017-06-30 | 2.03% | -22.52% | 275.93% | 55/68 | 5.23% | 济川药业 | 10.07% | 行业排名> |
| 2017-03-31 | 0.54% | -23.94% | -88.36% | 54/68 | 2.66% | ST葫芦娃 | 46.01% | 行业排名> |
| 2016-12-31 | 4.64% | 4.04% | 10.21% | 54/68 | 10.19% | 济川药业 | 24.2% | 行业排名> |
| 2016-09-30 | 4.21% | -21.46% | 60.69% | 45/68 | 9.47% | *ST大药 | 15.31% | 行业排名> |
| 2016-06-30 | 2.62% | -27.62% | 269.01% | 49/68 | 5.15% | 济川药业 | 14.64% | 行业排名> |
| 2016-03-31 | 0.71% | -11.25% | -84.08% | 52/68 | 4.17% | 济川药业 | 7.64% | 行业排名> |